Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

HomeStreet Stock Loved By Fund Manager Matthew Lindenbaum

HomeStreet stock: Matthew Lindenbaum’s hedge fund, Basswood Capital, recently increased its stake in HomeStreet Inc (NASDAQ:HMST). The hedge fund added around 772,200 shares to its position in the company, a filing with the SEC showed. In this way, Basswood currently holds almost 896,500 shares of Homestreet, equivalent to 6.22% of the company, with the value of the position amounting to some $17.3 million.

HomeStreet Inc (NASDAQ:HMST)

Homestreet is a financial company with subsidiaries HomeStreet Bank and HomeStreet Capital Corporation. Homestreet Bank recently enlarged its operations in California by adding six new loan centers that will operate in Northern and Central California, a statement on the company’s website showed. Homestreet is also currently in the process of acquiring two other banks, Fortune Bank located in Seattle and Yakima, Washington-based, Yakima National Bank including its parent company YNB Financial Services Corp.. The value of the deals amounts to a combined $37.3 million.

Pentwater Capital Management, managed by Matthew Halbower, Steven Owsley’s Madison Street Partners and Israel Englander’s Millennium Management are also bullish on Homestreet stock.

Recommended Reading:

Is There Any Value in Bill Ackman’s Holdings?

2 Billionaire Interviews You Need To Watch

Should Investors Follow Carl Icahn Into This Auto Supplier?

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!